Muniz Fernando Sebastian Moreira - 18 Mar 2026 Form 3 Insider Report for Sofgen Pharma S.A. (PROCF)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
30 Mar 2026, 08:09:19 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Freddy Andres Lozano Reyes, attorney-in-fact.

Key filing fact

Muniz Fernando Sebastian Moreira filed Form 3 for Sofgen Pharma S.A. (PROCF) on 30 Mar 2026.

Key facts

  • This page summarizes Muniz Fernando Sebastian Moreira's Form 3 filing for Sofgen Pharma S.A. (PROCF).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Mar 2026, 08:09.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002124183 Primary reporting owner

Moreira Muniz Fernando Sebastian

Relationship
Director, 10%+ Owner
Address
11600 MIRAMAR PARKWAY, SUITE 300, MIRAMAR
Signature
/s/ Freddy Andres Lozano Reyes, attorney-in-fact.
Signature date
30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PROCF holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
305,309,149
Date
18 Mar 2026
Ownership
By Becaril S.A.
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PROCF holding Derivative

Warrant to Purchase Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
By Becaril S.A.
Underlying class
Ordinary Shares
Underlying amount
19,800,411
Exercise price
$0.0631
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents Ordinary Shares beneficially owned by Becaril S.A. ("Becaril"), an entity controlled by Mr. Moreira Muniz.

Footnote F2

Represents a warrant to purchase Ordinary Shares beneficially owned by Becaril, an entity controlled by Mr. Moreira Muniz.

SEC remarks

See Exhibit 24 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .